Desvenlafaxine extended-release - Osmotica PharmaceuticalAlternative Names: Desvenlafaxine ER - Osmotica Pharmaceutical; Khedezla
Latest Information Update: 30 Sep 2013
At a glance
- Originator Osmotica Pharmaceutical
- Class Antidepressants; Cyclohexanols; Small molecules
- Mechanism of Action Adrenergic uptake inhibitors; Serotonin uptake inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Major depressive disorder
Most Recent Events
- 27 Sep 2013 Launched for Major depressive disorder in USA (PO)
- 10 Jul 2013 Registered for Major depressive disorder in USA (PO)